Ibrance (Palbociclib) Capsules – 125 mg

Oral therapy for HR+/HER2- breast cancer.

SKU: ETH-IBRANCE-125MG Category:
Description

Ibrance (palbociclib) is a CDK4/6 inhibitor used in combination with hormonal therapy to treat HR+/HER2- advanced or metastatic breast cancer. Taken orally once daily for 21 days, followed by 7 days off treatment.

Reviews (0)

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.